Santen Pharmaceutical Co., Ltd. (SNPHY)
11.19
+0.42
(+3.90%)
USD |
OTCM |
Oct 23, 16:00
Santen Pharmaceutical Market Cap : 3.594B for Oct. 23, 2026
Market Cap Chart
Historical Market Cap Data
| Date | Value |
|---|---|
| October 23, 2026 | 3.594B |
| October 22, 2026 | 3.459B |
| October 21, 2026 | 3.596B |
| October 20, 2026 | 3.649B |
| October 19, 2026 | 3.536B |
| October 16, 2026 | 3.500B |
| October 15, 2026 | 3.482B |
| October 14, 2026 | 3.504B |
| October 13, 2026 | 3.513B |
| October 12, 2026 | 3.318B |
| October 09, 2026 | 3.435B |
| October 08, 2026 | 3.421B |
| October 07, 2026 | 3.434B |
| October 06, 2026 | 3.286B |
| October 05, 2026 | 3.430B |
| October 02, 2026 | 3.389B |
| October 01, 2026 | 3.572B |
| September 30, 2026 | 3.483B |
| September 29, 2026 | 3.387B |
| September 28, 2026 | 3.499B |
| September 25, 2026 | 3.549B |
| September 24, 2026 | 3.453B |
| September 23, 2026 | 3.488B |
| September 22, 2026 | 3.536B |
| September 21, 2026 | 3.514B |
| Date | Value |
|---|---|
| September 18, 2026 | 3.562B |
| September 17, 2026 | 3.674B |
| September 16, 2026 | 3.437B |
| September 15, 2026 | 3.588B |
| September 14, 2026 | 3.593B |
| September 11, 2026 | 3.620B |
| September 10, 2026 | 3.507B |
| September 09, 2026 | 3.750B |
| September 08, 2026 | 3.694B |
| September 04, 2026 | 3.768B |
| September 03, 2026 | 3.838B |
| September 02, 2026 | 3.607B |
| September 01, 2026 | 3.709B |
| August 31, 2026 | 3.857B |
| August 28, 2026 | 3.806B |
| August 27, 2026 | 3.752B |
| August 26, 2026 | 3.938B |
| August 25, 2026 | 3.782B |
| August 24, 2026 | 3.784B |
| August 21, 2026 | 3.806B |
| August 20, 2026 | 3.981B |
| August 19, 2026 | 3.832B |
| August 18, 2026 | 3.875B |
| August 17, 2026 | 3.986B |
| August 14, 2026 | 3.864B |
Market Capitalization Definition
Market Capitalization measures the total value of a company based on their stock price multiplied by the shares outstanding. This metric is important because it gives you an idea of the size of a company, and how the size has changed over time. When studying companies from a relative basis, it would make sense to compare companies that have a similar market capitalization because factors like market share, economies of scale, and business models would also be similar.
Market Cap Range, Past 5 Years
--
Minimum
--
Maximum
--
Average
--
Median
Market Cap Benchmarks
| Takeda Pharmaceutical Co., Ltd. | 63.97B |
| Daiichi Sankyo Co., Ltd. | 32.48B |
| Eisai Co., Ltd. | 9.186B |
| Chugai Pharmaceutical Co., Ltd. | 70.88B |
| Ono Pharmaceutical Co., Ltd. | 7.428B |
Market Cap Related Metrics
| PE Ratio | 14.57 |
| PS Ratio | 1.953 |
| PEG Ratio | 0.5607 |
| Price to Book Value | 1.945 |
| Price | 11.19 |
| Earnings Yield | 6.86% |
| PEGY Ratio | 0.5607 |
| Operating PE Ratio | 12.46 |